AG
AgomAb Therapeutics N.V. American Depositary Shares
AGMB · NASDAQ
$11.70 -4.57% (-$0.56)
1M -5.07%
Valuation
-
N/A P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
20 /100
Unstable Beta 1.66x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AGMB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tim Knotnerus
Employees
62
Headquarters
Antwerp
Prihajajoči dogodki
03 MAR.
Earnings
Upcoming earnings report